Anticoagulation use and Hemorrhagic Stroke in SARS-CoV-2 Patients Treated at a New York Healthcare System

Alexandra Kvernland(NYU Langone Health), Kara Melmed(NYU Langone Health), Seena Dehkharghani(NYU Langone Health), Maksim Shapiro(Barrow Neurological Institute), Shadi Yaghi, Ariane Lewis(NYU Langone Health), Brian Mac Grory(Duke University), Nils Henninger(University of Massachusetts Chan Medical School), Jose Torres(Norwegian Womens Public Health Association), Adam de Havenon(University of Utah), Howard A. Riina(NYU Langone Health), Peter Kim Nelson(NewYork–Presbyterian Hospital), Barry Czeisler(NYU Langone Health), Koto Ishida(Norwegian Womens Public Health Association), Aaron Lord(Norwegian Womens Public Health Association), Omar Tanweer(NYU Langone Health), Jennifer Frontera(Norwegian Womens Public Health Association), Erez Nossek(NYU Langone Health), D. Ethan Kahn(NYU Langone Health), Ting Zhou(Yale University), David Gordon(NYU Langone Health), Rajan Jain(NYU Langone Health), Arooshi Kumar(NYU Langone Health), Eytan Raz(NYU Langone Health)
Neurocritical Care
August 24, 2020
10.1007/s12028-020-01077-0
Cited by 77

Related Papers

Diverse functional autoantibodies in patients with COVID-19
|Nature|2021|984
SARS-CoV-2 and Stroke in a New York Healthcare System
|Stroke|2020|749
Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
|Stroke|2017|525
Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms: Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial
|Neurosurgery|2016|440
The New York Islands AVM Study
|Stroke|2003|361